There were 1,596 press releases posted in the last 24 hours and 402,344 in the last 365 days.

Medical Neurogenetics, LLC Develops Anticonvulsant-Resistant Epilepsy Rapid Evaluation Testing

Medical Neurogenetics, LLC

Metabolic and genetic results are returned as testing is completed within 7 days, allowing critical clinical decision making.

ATLANTA, GEORGIA, USA, August 2, 2014 /EINPresswire.com/ -- Medical Neurogenetics, LLC is a clinical laboratory that performs complex histology, biochemical testing, metabolic testing, protein chemistry testing, and genetic testing. Diagnostic testing for neurologic and cardiologic diseases are emphasized. With the Medical Neurogenetics, LLC propietary SmartDx search engine, Next Generation Sequencing can be focused on cost effective patient diagnosis. By leveraging the combined stregths of the diagnostic platforms, Medical Neurogenetics, LLC recently launched Anticonvulsant-Resistant Epilepsy Rapid Evaluation Testing. Results are delivered to the clinician as they are completed, allowing rapid implementation into patient diagnostic and management strategies. Testing includes metabolic and genetic testing for clinically actionable diseases. All testing is completed in under seven days. With approximately 700 institutions world wide, Medical Neurogenetics, LLC is a leader in developing testing that is performed rapidly, is useful in clinical diagnosis and management, and provides the most cost effective testing options.

John M. Shoffner, MD
Medical Neurogenetics, LLC
678-357-9903
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.